ListarDepartamento de Bioquímica y Biología Molecular por tema "Sorafenib"
Mostrando ítems 1-1 de 1
-
Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells
(MDPI, 2019)Sorafenib is the first-line recommended therapy for patients with advanced hepatocarcinoma (HCC) in de-differentiation stage (presenting epithelial–mesenchymal transition, EMT). We studied the role of the thioredoxin system ...